368 related articles for article (PubMed ID: 16166313)
21. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
22. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene].
Yang J; Wang YX; Guan XQ; Ma CG; Wang LS; Song HY
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):217-22. PubMed ID: 15966325
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma.
Guo SW; Che HM; Li WZ
Cancer Sci; 2011 May; 102(5):1038-44. PubMed ID: 21255189
[TBL] [Abstract][Full Text] [Related]
24. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
25. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.
Ma HI; Guo P; Li J; Lin SZ; Chiang YH; Xiao X; Cheng SY
Cancer Res; 2002 Feb; 62(3):756-63. PubMed ID: 11830530
[TBL] [Abstract][Full Text] [Related]
26. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments.
Li F; Yang J; Liu X; He P; Ji S; Wang J; Han J; Chen N; Yao L
Biochem Biophys Res Commun; 2000 Nov; 278(3):821-5. PubMed ID: 11095991
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways.
Perri SR; Martineau D; François M; Lejeune L; Bisson L; Durocher Y; Galipeau J
Mol Cancer Ther; 2007 Feb; 6(2):441-9. PubMed ID: 17308045
[TBL] [Abstract][Full Text] [Related]
28. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
29. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
30. [Inhibition of human glioma growth in nude mice by local secretion of angiostatin K(1-3)].
Wu J; Zhang X; Gao D
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):861-4. PubMed ID: 11218885
[TBL] [Abstract][Full Text] [Related]
31. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
34. Angiostatin K(1-3) gene for treatment of human gliomas: an experimental study.
Zhang X; Wu J; Fei Z; Gao D; Li X; Liu X; Liang J; Wang X
Chin Med J (Engl); 2000 Nov; 113(11):996-1001. PubMed ID: 11776134
[TBL] [Abstract][Full Text] [Related]
35. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
37. Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
Solly F; Fish R; Simard B; Bolle N; Kruithof E; Polack B; Pernod G
Cancer Gene Ther; 2008 Oct; 15(10):685-92. PubMed ID: 18535615
[TBL] [Abstract][Full Text] [Related]
38. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
[TBL] [Abstract][Full Text] [Related]
39. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
40. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
